We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
(-4.4%)
Cap. Flow
+$802M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$78.7M |
| 2 |
XYZ
Block Inc
XYZ
|
+$49.3M |
| 3 |
Visa
V
|
+$46.1M |
| 4 |
Apple
AAPL
|
+$45.4M |
| 5 |
DoorDash
DASH
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$23.2M |
| 3 |
Williams-Sonoma
WSM
|
+$22.2M |
| 4 |
Broadcom
AVGO
|
+$20.3M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.67% |
| 2 | Financials | 14.43% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTV
3251
Artiva Biotherapeutics
ARTV
$551M
| $43.5K | ﹤0.01% |
14,493
+1,614
| +13% | +$8.71K |
|
3252
Cadeler
CDLR
$2.28B
| $42.6K | ﹤0.01% |
2,167
+675
| +45% | +$13.6K |
|
3253
Emergent Biosolutions
EBS
$248M
| $42.4K | ﹤0.01% |
8,731
-1,508
| -15% | -$12.5K |
|
3254
Cenovus Energy
CVE
$52.1B
| $42.4K | ﹤0.01% |
3,048
-602
| -16% | -$8.67K |
|
3255
Ternium
TX
$10.6B
| $42.2K | ﹤0.01% |
1,354
-102
| -7% | -$3.09K |
|
3256
Southland Holdings
SLND
$31.4M
| $42.1K | ﹤0.01% |
14,080
+4,649
| +49% | +$15.1K |
|
3257
Amprius Technologies
AMPX
$1.73B
| $42K | ﹤0.01% |
15,690
+5,951
| +61% | +$17.6K |
|
|
RDNW
3258
RideNow Group
RDNW
$262M
| $41.8K | ﹤0.01% |
14,827
-1,114
| -7% | -$4.59K |
|
3259
Teck Resources
TECK
$32.6B
| $41.3K | ﹤0.01% |
1,134
+187
| +20% | +$7.76K |
|
|
EH
3260
EHang Holdings
EH
$435M
| $40.7K | ﹤0.01% |
1,947
-641
| -25% | -$13K |
|
3261
LiveOne
LVO
$58.2M
| $40.4K | ﹤0.01% |
5,777
+277
| +5% | +$2.73K |
|
3262
Quest Resource Holding
QRHC
$31.6M
| $39.5K | ﹤0.01% |
15,207
+1,267
| +9% | +$6K |
|
|
LX
3263
LexinFintech Holdings
LX
$241M
| $39.5K | ﹤0.01% |
3,917
-4,008
| -51% | -$33.6K |
|
3264
Tenaya Therapeutics
TNYA
$163M
| $39.4K | ﹤0.01% |
69,193
-11,493
| -14% | -$11.3K |
|
3265
Ecopetrol
EC
$34.5B
| $38.5K | ﹤0.01% |
3,685
-4,454
| -55% | -$42.5K |
|
|
DRD
3266
DRDGold
DRD
$2.05B
| $38.2K | ﹤0.01% |
2,471
-4,195
| -63% | -$48.1K |
|
3267
Comp X International
CIX
$371M
| $38K | ﹤0.01% |
1,836
-6,466
| -78% | -$155K |
|
3268
Telomir Pharmaceuticals
TELO
$79.8M
| $37.9K | ﹤0.01% |
11,732
+3,132
| +36% | +$13.7K |
|
|
NEXN
3269
Nexxen International
NEXN
$607M
| $37.2K | ﹤0.01% |
4,457
+823
| +23% | +$7.42K |
|
3270
Telefônica Brasil
VIV
$19.2B
| $36.9K | ﹤0.01% |
4,233
+3,266
| +338% | +$28K |
|
3271
iShares MSCI Thailand ETF
THD
$372M
| $36.9K | ﹤0.01% |
710
+110
| +18% | +$6.15K |
|
|
BIOA
3272
BioAge Labs
BIOA
$538M
| $36.8K | ﹤0.01% |
9,800
+5,942
| +154% | +$27.5K |
|
|
EVBN
3273
DELISTED
Evans Bancorp Inc
EVBN
| $36.5K | ﹤0.01% |
937
| – | – |
|
3274
MINISO
MNSO
$3.75B
| $36.4K | ﹤0.01% |
1,970
-3,331
| -63% | -$72.7K |
|
3275
VirTra
VTSI
$34.5M
| $35.9K | ﹤0.01% |
8,811
+718
| +9% | +$4.29K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
- RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
- RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
- RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
- RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
- RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
- RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.
Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.